Effect of COVID-19 Pandemic on Behavioral and Pharmacological Treatment Outcomes in Attention Deficit Hyperactivity Disorder (ADHD) Children

Faculty of Pharmaceutical Sciences, Burapha University0 个研究点目标入组 80 人开始时间: 2022年7月14日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1) was Thai people with 13-digit identification.
•2) aged 14 years or younger during COVID-19 outbreak (after 3 April 2020).
•3) were diagnosed Attention Deficit Hyperactivity Disorder (ADHD): ICD-10-TM codes F90 before and during COVID-19 outbreak.
•4) had at least one patient data recorded or medical record before and during COVID-19 outbreak.
•5) had records of pharmacological outcome or behavioral outcome.
•6) had records of demographic data, Covid-19 pandemic data, or clinical and pharmacological factors.

•1)denied to participate in this project.
•2)were diagnosed Autistic traits who would be represented the unobvious differentiation of pharmacological outcome and behavioral outcome.
•3) loss of follow up or loss of contact information.
•4) were study subjects with missing data on pharmacological outcome, behavioral outcome, demographic data, Covid-19 pandemic data, or clinical and pharmacological factors.

发起方

Faculty of Pharmaceutical Sciences, Burapha University